Ivermectin Market Definition
Ivermectin is an anthelmintic medication which is a prescription drug used to treat many types of parasite infections available in different forms like oral tablets, cream, and lotion under different brand names Stromectol, Soolantra. Ivermectin treat the skin infections called strongyloidiasis, it is also used to control onchocerciasis helping improve quality of life, people with weak immune system curing the infections can reduce the risk of developing a life-threatening infection. Currently, Ivermectin is being researched on the treatment for virus SARS-CoV-2 that causes COVID-19.
The market study is broken down, by Application (Hospitals, Clinics and Research Centre) and major geographies with country level splits.
Merck & Co., Inc. (United States), Perrigo Company plc (Ireland), Galderma Laboratories LP (United States), MedinCell S.A (France), Hebei Veyong Animal Pharmaceutical Co., Ltd., (China), Hovione Farmaciencia (Portugal), Shandong Qilu King-Phar Pharmaceutical Co., Ltd. (China) and Zydus Cadila (India) are some of the key players that are part of study coverage.
AdvanceMarketAnalytics has segmented the market of Global Ivermectin market by Type, Application and Region.
On the basis of geography, the market of Ivermectin has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Form, the sub-segment i.e. Oral Tablet will boost the Ivermectin market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Aged 18-65 Years will boost the Ivermectin market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
On 6th April 2020, MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin. and First in-vitro validation of the impact of Ivermectin on Covid-19 by Australian researchers. Future clinical studies will have to confirm the action of Ivermectin on the Covid-19 virus, and the potential effectiveness of a long-acting injectable on its prevention and therefore breaking the chain of transmission.
"Ivermectin tablets are approved for use in humans for the treatment of some parasitic worms (intestinal strongyloidiasis and onchocerciasis) and ivermectin topical formulations are approved for human use by prescription only for the treatment of external parasites such as headlice and for skin conditions such as rosacea. Ivermectin is FDA-approved for use in animals for the prevention of heartworm disease in some small animal species, and for the treatment of certain internal and external parasites in various animal species. People should never take animal drugs, as the FDA has only evaluated their safety and effectiveness in the particular species for which they are labeled. Using these products in humans could cause serious harm."
- Continuous Research and Development on Ivermectin for Drug Discovery for Severe Diseases
- Increasing Prevalence of Parasitic Infections on Skin
- Demand for Parasitic Drug for Animals
- Increased Spending on Pharmaceutical Industry
- Clinical Trials on Ivermectin for Drug Testing
- Side Effects Associated with Consumption of Ivermectin
- Stringent Regulatory Standards on Ivermectin
- Less Awareness about the Skin Related Problems and its Treatment
Key Target Audience
Ivermectin Manufacturers, Ivermectin International Traders, Ivermectin Distributors and Suppliers, Research and Development Institutes, Potential Investors, Regulatory Bodies and Others
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase